Back
Accenture PLC 10K Form
Buy
52
ACN
Accenture PLC
Last Price:
358.61
Seasonality Move:
4.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-03-21 | 10Q | ACN/Accenture PLC Quarterly |
| 2023-12-19 | 10Q | ACN/Accenture PLC Quarterly |
| 2023-06-22 | 10Q | ACN/Accenture PLC Quarterly |
| 2023-03-23 | 10Q | ACN/Accenture PLC Quarterly |
| 2022-12-16 | 10Q | ACN/Accenture PLC Quarterly |
| 2022-06-23 | 10Q | ACN/Accenture PLC Quarterly |
Receive ACN News And Ratings
See the #1 stock for the next 7 days that we like better than ACN
ACN Financial Statistics
Sales & Book Value
| Annual Sales: | $64.9B |
|---|---|
| Cash Flow: | $3.18B |
| Price / Cash Flow: | 26.48 |
| Annual Sales: | $45.24 |
| Price / Book: | 7.92 |
Profitability
| EPS (TTM): | 11.43000 |
|---|---|
| Net Income (TTM): | $7.26B |
| Gross Margin: | $21.16B |
| Return on Equity: | 26% |
| Return on Assets: | 13.75% |
Accenture PLC Earnings Forecast
Key Accenture PLC Financial Ratios
- The Gross Profit Margin over the past 24 years for ACN is 32.61%.
- The Selling, General & Administrative Expenses for ACN have been equal to 17.15% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.81% of Operating Income.
- The Net Earning history of ACN is 11.19% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 19 years.
Accenture PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | IT Services |
| Sector: | Information Technology |
| Current Symbol: | ACN |
| CUSIP: | G1151C |
| Website: | accenture.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 1.1 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 31.35 |
|---|---|
| Forward P/E Ratio: | 25.45 |
ACN Technical Analysis vs Fundamental Analysis
Buy
52
Accenture PLC (ACN)
is a Buy
Is Accenture PLC a Buy or a Sell?
-
Accenture PLC stock is rated a Buy
The current Accenture PLC [ACN] share price is $358.66. The Score for ACN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.